{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8072387", "DateCompleted": {"Year": "1994", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0024-3205", "JournalIssue": {"Volume": "55", "Issue": "11", "PubDate": {"Year": "1994"}}, "Title": "Life sciences", "ISOAbbreviation": "Life Sci"}, "ArticleTitle": "Effects of prolonged ingestion of graded doses of licorice by healthy volunteers.", "Pagination": {"StartPage": "863", "EndPage": "872", "MedlinePgn": "863-72"}, "Abstract": {"AbstractText": ["Licorice can induce a hypermineralocorticoid syndrome. Current literature usually refers to the effects of sweets containing glycyrrhizin, but little is known about the consequences of a prolonged intake of \"pure licorice\". We administered graded daily doses of dried, aqueous extract of licorice root, containing 108, 217, 380 and 814 mg of glycyrrhizin, to 4 groups of 6 healthy volunteers of both sexes for 4 weeks. No significant effects occurred in groups 1 and 2. After 2 weeks, side effects leading to withdrawal from the protocol occurred in a female in group 3 (headache), a male with a family history of hypertension in group 4 (arterial hypertension), and a female also taking oral contraceptives in group 4 (hypertension, hypokalaemia and peripheral edema). In group 4, transient reduction in kalaemia and increase in body weight were found after 1 and 2 weeks, respectively. A depression of plasma renin activity occurred in groups 3 and 4. In healthy subjects, only the highest doses of licorice led to untoward effects. These were favoured by subclinical disease or oral contraceptives, and were less common and pronounced than what has been reported after the intake of glycyrrhizin taken as such or as a flavouring agent in confectionery products."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Patologia Speciale Medica I, University of Bologna."}], "LastName": "Bernardi", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "D'Intino", "ForeName": "P E", "Initials": "PE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Trevisani", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cantelli-Forti", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Raggi", "ForeName": "M A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Turchetto", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gasbarrini", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Clinical Trial", "Comparative Study", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Life Sci", "NlmUniqueID": "0375521", "ISSNLinking": "0024-3205"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "9NEZ333N27", "NameOfSubstance": "Sodium"}, {"RegistryNumber": "EC 3.4.23.15", "NameOfSubstance": "Renin"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}, {"RegistryNumber": "RWP5GA015D", "NameOfSubstance": "Potassium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": [], "DescriptorName": "Diet"}, {"QualifierName": ["drug effects"], "DescriptorName": "Diuresis"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Glomerular Filtration Rate"}, {"QualifierName": ["administration & dosage", "adverse effects", "analogs & derivatives", "pharmacology"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": [], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": [], "DescriptorName": "Hematocrit"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Natriuresis"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood", "urine"], "DescriptorName": "Potassium"}, {"QualifierName": ["blood"], "DescriptorName": "Renin"}, {"QualifierName": ["blood", "urine"], "DescriptorName": "Sodium"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "1", "Day": "1"}, {"Year": "1994", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8072387", "10.1016/0024-3205(94)90042-6", "0024-3205(94)90042-6"]}}]}